Related Experiment Videos
Special indications in gamma knife surgery.
B Wowra1, A Muacevic, S Müller-Schunk
1German Gamma Knife Centre Munich, Munich, Germany. wowra@gammaknife.de
Acta Neurochirurgica. Supplement
|February 15, 2005
Summary
Gamma Knife Surgery for pilocytic astrocytoma (PA) is rare, mainly treating post-surgical remnants. Typical PAs show better outcomes and lower risks than atypical PAs after treatment.
Area of Science:
- Neurosurgery
- Radiation Oncology
- Pediatric Oncology
Background:
- Pilocytic astrocytoma (PA) is a rare indication for Gamma Knife Surgery (GKS).
- GKS is typically used for residual tumor after surgical debulking.
- Prognosis varies based on tumor characteristics.
Purpose of the Study:
- To evaluate the efficacy of Gamma Knife Surgery for pilocytic astrocytoma.
- To compare outcomes between typical and atypical pilocytic astrocytoma treated with GKS.
Main Methods:
- Differentiated patients into 'typical' (WHO Grade I, no prior radiotherapy, no cysts) and 'atypical' (malignant transformation, prior radiotherapy, and/or cysts) groups.
- Assessed outcomes following Gamma Knife Surgery.
Main Results:
- Outcomes were significantly more favorable for typical pilocytic astrocytoma compared to atypical cases.
- Typical PAs achieved high tumor control with minimal side effects.
Conclusions:
- Gamma Knife Surgery can achieve high tumor control with low side effects in typical pilocytic astrocytoma.
- Atypical pilocytic astrocytoma present a less favorable prognosis following Gamma Knife Surgery.